Mammogram Giant Adjusts as Doctors Cut Back on Breast Screening

  • Hologic shares up 40% this year as sales top estimates
  • Company bets on 3-D to give doctors more useful images

Doctors are questioning the gospel of the annual mammogram to detect cancer -- a potential blow to the biggest maker of mammography equipment.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.